I’m sure Howie would make a good CEO for any biopharma company with his track record and associations, but the extra attraction of keeping him on for any buyer would be his knowledge and expertise in BOT’s pipeline of products, not just SB. Do you think any buyer would just be happy to let all BOT senior management just walk away after any purchase of the company? That’s not usually how it works.
- Forums
- ASX - By Stock
- BOT
- Ann: Notification regarding unquoted securities - BOT
Ann: Notification regarding unquoted securities - BOT, page-18
-
-
- There are more pages in this discussion • 68 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BOT (ASX) to my watchlist
|
|||||
Last
33.0¢ |
Change
0.015(4.76%) |
Mkt cap ! $597.3M |
Open | High | Low | Value | Volume |
32.5¢ | 33.5¢ | 32.3¢ | $1.265M | 3.862M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 129446 | 32.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
33.0¢ | 131308 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 129446 | 0.325 |
10 | 369244 | 0.320 |
9 | 838174 | 0.315 |
13 | 447023 | 0.310 |
9 | 117319 | 0.305 |
Price($) | Vol. | No. |
---|---|---|
0.330 | 131308 | 2 |
0.335 | 392300 | 6 |
0.340 | 500194 | 10 |
0.345 | 359661 | 5 |
0.350 | 126810 | 6 |
Last trade - 16.10pm 09/08/2024 (20 minute delay) ? |
Featured News
BOT (ASX) Chart |